Document is current

Article History

Accepted: 7 September 2021

First Online: 9 November 2021

Declarations

:

: This research received no external funding. Tabula Rasa HealthCare (TRHC) sponsors TRHC Precision Pharmacotherapy Research and Development Institute research activities. The funder (TRHC board of directors) had no role in the study design or the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

: Sweilem B Al Rihani, Malavika Deodhar, Lucy I Darakjian, Pamela Dow, Matt K Smith, Ravil Bikmetov, Jacques Turgeon, and Veronique Michaud are employees and shareholders of Tabula Rasa HealthCare.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: SBAR, MD, LID, PD, JT, and VM wrote the manuscript. PD, JT, and VM edited the manuscript. SBAR, MD, LID, PD, MKS, RB, JT, and VM provided graphics for the manuscript. SBAR, MD, LID, MKS, and RB performed research for the manuscript. JT and VM designed the research. JT and VM supervised the research. All authors read and approved the final version of the paper, and agree to be accountable for the work presented in the manuscript.

: The authors thank Dana Filippoli, Communications Consultant, TRHC, for her comprehensive review and comments on the manuscript.